Application
Anti-phosphotyrosine, clone 4G10 ZooMAb, Cat. No. ZMS16282, is a recombinant Mouse monoclonal antibody that detects phosphotyrosine and is tested for use in Immunocytochemistry, Immunohistochemistry (Paraffin), and Western Blotting.
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected phosphotyrosine in A431cells treated with EGF (50 ng/mL; 15 min)Immunohistochemistry (Paraffin) Analysis: A 1:1,000 dilution from a representative lot detected phosphotyrosine in human breast cancer tissue sections.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Immunogen
KLH-conjugated Phosphotyramine.
Legal Information
ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
Physical form
Purified recombinant mouse monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.
Reconstitution
0.03 mg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Specificity
Clone 4G10 is a ZooMAb mouse recombinant monoclonal antibody that specifically detects proteins with phosphotyrosine.
Storage and Stability
Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
Target description
Phosphorylation on tyrosine residues is one of the major signal transduction mechanism that regulates intercellular and intracellular signaling in multicellular organisms. Dysregulation of protein tyrosine phosphorylation leads to several diseases, including cancer, diabetes, and several neurodegenerative disorders. Tyrosine residues in proteins can be phosphorylated by protein tyrosine kinases resulting in the formation of phosphotyrosine. Tyrosine phosphorylation is one of the key steps in signal transduction and regulation of enzymatic activity. Anti-phosphotyrosine antibodies are commonly used in Western blotting application after the targeted proteins have been immunoprecipitated to measure the tyrosyl phosphorylation of the proteins. They can also be used directly in cell lysates to examine the overall change of tyrosine phosphorylation level in response to various hormones, cytokines, and other treatments. Clone 4G10 is one of the best monoclonal antibody for the detection of tyrosine phosphorylation. This clone provides high sensitivity and can detect tyrosine phosphorylation of multiple proteins. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.
This product has met the following criteria to qualify for the following awards: